Form D · Other
Nutraceutical Innovations, Inc.
Fayetteville, AR · CIK 0001572863
Offering snapshot reported Mar 26, 2013 · SEC filing
- Reported sold
- $125K Offering amount: $350K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 20, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2013 | Initial | $125,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-193891
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| n/a | None |
Source: Form D, filed Mar 26, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Collis Geren | Director |
| Leo Gingras | Director |
| Calvin Goforth | Director, Executive |
| Navam Hettiarachchy | Director |
| Mark Calvin Kidd | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
535 W. Research Center Blvd. Suite 135
Fayetteville, AR, 72701
Fayetteville, AR, 72701